After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Drug Manufacturers – Specialty & Generic industry segment, falling under the Healthcare sector. The current market capitalization of Pacira BioSciences Inc is $1.13B. A total of 1.58 million shares were traded on the day, compared to an average of 728.53K shares.
In the most recent transaction, SLONIN JONATHAN sold 879 shares of PCRX for 18.40 per share on Jan 06 ’25. After the transaction, the Chief Medical Officer now owns 93,444 company shares. In a previous transaction on Jan 06 ’25, SLONIN JONATHAN bought 879 shares at 18.40 per share.
Among the insiders who sold shares, GAUGLER DARYL disposed of 500 shares on Dec 13 ’24 at a per-share price of $19.76. This resulted in the Chief Operating Officer holding 115,200 shares of PCRX after the transaction. In another insider transaction, GAUGLER DARYL bought 500 shares at $19.76 per share on Dec 13 ’24.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, PCRX has a high of $34.01 and a low of $11.16.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. PCRX’s latest balance sheet shows that the firm has $656.41M in Cash & Short Term Investments as of fiscal 2021. There were $1.13B in debt and $521.12M in liabilities at the time. Its Book Value Per Share was $16.24, while its Total Shareholder’s Equity was $730.41M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PCRX is Buy with a score of 3.13.
